By continuing to use the site you agree to our Privacy & Cookies policy

New drug for diabetes approved

NICE has approved a drug for treating patients with type 2 diabetes who are intolerant of either metformin, sulphonylurea, thiazolidinediones or dipeptidyl peptidase-4 inhibitors.

Get unlimited access

As a subscriber you will benefit from:

  • Full online and mobile access to news and opinion stories
  • Customised email alerts straight to your inbox (over 30 alerts available)
  • 4,500 practice articles in our archive 
  • Over £500 worth of CPD learning units 
or

newsletterpromo